Nik Hirani

4.7k total citations · 1 hit paper
54 papers, 2.3k citations indexed

About

Nik Hirani is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Nik Hirani has authored 54 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 17 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Nik Hirani's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (21 papers), Immune Response and Inflammation (7 papers) and Pulmonary Hypertension Research and Treatments (7 papers). Nik Hirani is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (21 papers), Immune Response and Inflammation (7 papers) and Pulmonary Hypertension Research and Treatments (7 papers). Nik Hirani collaborates with scholars based in United Kingdom, United States and India. Nik Hirani's co-authors include Athol U. Wells, A. John Simpson, Irfan Rahman, Alison C. MacKinnon, Michael Gibbons, Christopher Haslett, Hakon Leffler, Stuart J. Forbes, Tamara Delaine and Sarah L. Farnworth and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Nik Hirani

50 papers receiving 2.2k citations

Hit Papers

Interstitial lung disease guideline 2008 2026 2014 2020 2008 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Interstitial lung disease guideline
    2008 624 citations Athol U. Wells, Nik Hirani Thorax profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nik Hirani United Kingdom 19 1.2k 692 485 420 226 54 2.3k
Dmitri V. Pechkovsky Canada 24 1.2k 1.0× 590 0.9× 568 1.2× 575 1.4× 238 1.1× 32 2.3k
Bernt van den Blink Netherlands 27 1.1k 0.9× 568 0.8× 809 1.7× 558 1.3× 382 1.7× 50 2.5k
Elizabeth F. Redente United States 30 1.4k 1.2× 733 1.1× 262 0.5× 626 1.5× 194 0.9× 59 2.6k
Yoshiki Ishii Japan 22 879 0.7× 433 0.6× 478 1.0× 398 0.9× 222 1.0× 84 1.9k
Masaki Okamoto Japan 29 1.0k 0.8× 723 1.0× 537 1.1× 732 1.7× 406 1.8× 128 2.6k
Monique Henket Belgium 25 1.4k 1.1× 692 1.0× 1.4k 2.8× 516 1.2× 187 0.8× 105 2.7k
Miguel Gaxiola Mexico 21 1.9k 1.5× 350 0.5× 534 1.1× 433 1.0× 287 1.3× 51 2.8k
Mitsuru Munakata Japan 25 1.3k 1.0× 332 0.5× 726 1.5× 261 0.6× 206 0.9× 116 2.2k
Anne Druilhe France 18 590 0.5× 654 0.9× 886 1.8× 933 2.2× 180 0.8× 26 2.3k
Etsuro Yamaguchi Japan 30 1.3k 1.1× 475 0.7× 950 2.0× 399 0.9× 287 1.3× 125 2.6k

Countries citing papers authored by Nik Hirani

Since Specialization
Citations

This map shows the geographic impact of Nik Hirani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nik Hirani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nik Hirani more than expected).

Fields of papers citing papers by Nik Hirani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nik Hirani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nik Hirani. The network helps show where Nik Hirani may publish in the future.

Co-authorship network of co-authors of Nik Hirani

This figure shows the co-authorship network connecting the top 25 collaborators of Nik Hirani. A scholar is included among the top collaborators of Nik Hirani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nik Hirani. Nik Hirani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vitiello, Giuseppe, Dhruv Parekh, Sophie Fletcher, et al.. (2025). Safety, Tolerability, and Pharmacokinetics of CHF10067 in Subjects With Idiopathic Pulmonary Fibrosis: A Phase Ib Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A2927–A2927.
2.
3.
4.
Hirani, Nik, et al.. (2024). Key regulators of hepatic stellate cell activation in alcohol liver Disease: A comprehensive review. International Immunopharmacology. 141. 112938–112938. 3 indexed citations
5.
Ford, Paul, Michael Kreuter, Kevin K. Brown, et al.. (2024). An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis. ERJ Open Research. 10(1). 636–2023. 2 indexed citations
6.
Invernizzi, Rachele, Mohammad Doroudian, Mohsen Moghoofei, et al.. (2022). Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 205(5). 550–562. 16 indexed citations
7.
Megía-Fernández, Alicia, Adam Marshall, Ahsan R. Akram, et al.. (2021). Optical Detection of Distal Lung Enzyme Activity in Human Inflammatory Lung Disease. SHILAP Revista de lepidopterología. 2021(2021). 9834163–9834163. 12 indexed citations
8.
9.
Akram, Ahsan R., Sunay V. Chankeshwara, Emma Scholefield, et al.. (2018). In situ identification of Gram-negative bacteria in human lungs using a topical fluorescent peptide targeting lipid A. Science Translational Medicine. 10(464). 69 indexed citations
10.
Vennelle, Marjorie, et al.. (2015). Sleep-disordered breathing and idiopathic pulmonary fibrosis—is there an association?. Sleep And Breathing. 19(2). 719–721. 15 indexed citations
11.
Xaubet, Antoni, Jürgen Behr, Elisabeth Bendstrup, et al.. (2013). Review of IPF diagnosis and management recommendations in Europe.. PubMed. 30(4). 249–61. 13 indexed citations
12.
O’Dwyer, David N., Michelle E. Armstrong, Glenda Trujillo, et al.. (2013). The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 188(12). 1442–1450. 123 indexed citations
13.
Lucas, Christopher D., David A. Dorward, Sarah Fox, et al.. (2013). Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung. Mucosal Immunology. 7(4). 857–868. 63 indexed citations
14.
Vennelle, Marjorie, et al.. (2013). Sleep-disordered breathing in idiopathic pulmonary fibrosis. European Respiratory Journal. 42(Suppl 57). P3814–P3814. 1 indexed citations
15.
Dhaliwal, Kevin, Emma Scholefield, David A. Ferenbach, et al.. (2012). Monocytes Control Second-Phase Neutrophil Emigration in Established Lipopolysaccharide-induced Murine Lung Injury. American Journal of Respiratory and Critical Care Medicine. 186(6). 514–524. 86 indexed citations
16.
MacKinnon, Alison C., Michael Gibbons, Sarah L. Farnworth, et al.. (2011). Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3. American Journal of Respiratory and Critical Care Medicine. 185(5). 537–546. 397 indexed citations
17.
Jenkins, Gísli, Andrew D. Blanchard, Zea Borok, et al.. (2011). In search of the fibrotic epithelial cell: opportunities for a collaborative network. Thorax. 67(2). 179–182. 13 indexed citations
18.
Wells, Athol U. & Nik Hirani. (2008). Interstitial lung disease guideline. Thorax. 63(Supplement 5). v1–v58. 624 indexed citations breakdown →
19.
Parmentier, Maryline, Nik Hirani, Irfan Rahman, et al.. (2000). Regulation of lipopolysaccharide-mediated interleukin-1beta release by N-acetylcysteine in THP-1 cells. European Respiratory Journal. 16(5). 933–939. 39 indexed citations
20.
Haslett, Christopher, Nik Hirani, A P Greening, et al.. (1998). Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma.. Journal of Clinical Investigation. 101(12). 2869–2874. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dmitri V. Pechkovsky Breakdown of academic impact, for papers by Bernt van den Blink Breakdown of academic impact, for papers by Elizabeth F. Redente Breakdown of academic impact, for papers by Yoshiki Ishii Breakdown of academic impact, for papers by Masaki Okamoto Breakdown of academic impact, for papers by Monique Henket Breakdown of academic impact, for papers by Miguel Gaxiola Breakdown of academic impact, for papers by Mitsuru Munakata Breakdown of academic impact, for papers by Anne Druilhe Breakdown of academic impact, for papers by Etsuro Yamaguchi
Rankless by CCL
2026